Cell and Gene Regulatory

  1. FDA Approval Of TREGZI Signals A New Era For Precision Engineered Cell Therapy 7/9/2026

    Following the FDA approval of TREGZI, Orca Bio's precision engineered allogeneic cell therapy is redefining stem cell transplantation through improved immune control, advanced manufacturing, and a platform designed to expand the future of cell therapy.

  2. Negative Stain TEM For Viral Particle Characterization 7/8/2026

    Standardized latex bead references combined with negative stain TEM provide precise viral particle characterization and consistent viral load quantification.

  3. Raw Materials For Biopharmaceutical Manufacturing 7/8/2026

    Reliable production depends on material quality, process fit, and regulatory confidence. Get a practical look at solutions and support across upstream, downstream, and formulation workflows.

  4. Maximizing Efficiency In Lentiviral Vector Manufacturing 7/8/2026

    Accelerate cell and gene therapy programs with scalable lentiviral vector manufacturing, delivering high titers, exceptional purity, and reliable clinical supply from gene to clinic.

  5. Optimizing Adenoviral Production With Adaptive Process Architecture 7/8/2026

    Speed adenoviral vector development with scalable suspension processes and hybrid purification workflows that improve yield, efficiency, and clinical readiness.

  6. Advancing AAV Therapies From Concept To Commercial Supply 7/8/2026

    Accelerate gene therapy development with a scalable AAV platform delivering high yield, reproducibility, integrated analytics, and reliable clinical supply from design to production.

  7. Viral Vector Solutions That Move Your Program Forward 7/8/2026

    Optimize your viral vector program with scalable manufacturing, advanced process development, regulatory-ready workflows, and integrated fill-finish solutions to accelerate market success.

  8. Automatic Filling And Capping Machine In Aseptic Conditions 7/7/2026

    AseptiFill is the Aseptic Filling and Capping Machine specifically designed for Pharma & Biotech companies, focused on small batch production of injectable products for pre-clinical and clinical trial studies. Suitable for Ready-To-Use (RTU) vials ISO 8362-1 and RayDyLyo® push-fit caps.

  9. Achieving Annex 1 Compliance In Sterile Manufacturing, Part 3: Building A Compliant Program 7/7/2026

    In this third and final article of this series, let's take a closer look at what a well-constructed Annex 1-compliant program looks like at each stage, from gap assessment through governance.

  10. QA Microbiology Isolators: ST-IS Series 7/6/2026

    Designed for pharmaceutical quality control and microbiology laboratories.